Feature Story  

FDA approves new drug for Alzheimer's disease: 'Meaningful results'

Tue, Jul 2, 2024
The FDA has approved a new medication for people with Alzheimer's disease. Eli Lilly's Kisunla (donanemab) is a once-monthly injection intended for adults with early symptomatic Alzheimer's disease.
  Newsifi

New York, New York

Email : info@newsifi.com